Analyst Reco. Summit Therapeutics Inc.

Stocks

SMMT

US86627T1088

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 01:10:33 2026-06-11 pm EDT			5-day change	1st Jan Change
13.30 ^USD	+1.95%		-10.85%	-24.36%

10:04am	Summit Therapeutics Withdraws Public Offering Due to Market Conditions	MT
Jun. 09	Summit Therapeutics Launches $500 Million Common Stock Public Offering	MT

Analyst Reco.

May. 22	Summit Therapeutics Shares Fall After HC Wainwright Downgrade	MT
May. 22	Bernstein Initiates Summit Therapeutics at Underperform	MT
May. 22	HC Wainwright Downgrades Summit Therapeutics to Neutral From Buy	MT
Dec. 17	Barclays Upgrades Summit Therapeutics to Equal Weight From Underweight, Adjusts Price Target to $18 From $16	MT
25-10-20	Summit Therapeutics Inc. Plans to Submit a BLA in Fourth Quarter 2025 for Ivonescimab Based on Harmoni Global Phase III Study Results	CI
25-09-17	Barclays Initiates Summit Therapeutics at Underweight With $13 Price Target	MT
25-09-04	Guggenheim Initiates Summit Therapeutics at Buy With $40 Price Target	MT
25-08-19	Piper Sandler Initiates Summit Therapeutics at Neutral With $21 Price Target	MT
25-08-13	Summit Therapeutics Pullback Seen as 'Overreaction' Amid Liquidity Options, Truist Says	MT
25-07-01	UBS Initiates Summit Therapeutics at Buy With $30 Price Target	MT
25-06-11	Leerink Partners Initiates Coverage on Summit Therapeutics With Underperform Rating, $12 Price Target	MT
25-05-08	TD Cowen Initiates Summit Therapeutics at Buy	MT
25-03-26	Citigroup Upgrades Summit Therapeutics to Buy From Neutral, Adjusts Price Target to $35 From $23	MT
25-03-21	Cantor Fitzgerald Initiates Summit Therapeutics at Overweight	MT
25-03-12	Evercore ISI Initiates Summit Therapeutics at Outperform With $30 Price Target	MT
25-02-28	Goldman Sachs Initiates Summit Therapeutics at Buy With $42 Price Target	MT
25-01-08	Truist Initiates Summit Therapeutics at Buy With $35 Price Target	MT
24-12-11	Wells Fargo Initiates Summit Therapeutics at Overweight With $30 Price Target	MT
24-12-06	Jefferies Initiates Summit Therapeutics at Buy With $31 Price Target	MT
24-11-04	JMP Securities Initiates Summit Therapeutics at Market Outperform With $32 Price Target	MT
24-09-27	Citigroup Downgrades Summit Therapeutics to Neutral From Buy, Adjusts Price Target to $23 From $19	MT
24-06-03	Stifel Adjusts Summit Therapeutics Price Target to $14 From $8, Maintains Buy Rating	MT
24-05-07	Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target	MT
24-03-26	Stifel Initiates Summit Therapeutics With Buy Rating, $8 Price Target	MT
20-11-18	SUMMIT THERAPEUTICS : HC Wainwright Downgrades Summit Therapeutics to Neutral from Buy	MT